MedTrace Logo

Efficacy of Almonds Added to Chronic Statin Therapy

NCT00603876 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-05-22

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effects of 100-110 grams of almonds (about ¾ cupful) daily on the lipoprotein profile when given to patients on a statin drug. The study will compare the effects on the lipoprotein profile to patients who eat almonds and those patients not eating almonds.

Conditions

Interventions

DIETARY_SUPPLEMENT

Almonds

100-110 grams (about 3/4 cupful)of almonds consumed daily for 28 days

Sponsors & Collaborators

  • Almond Board of California

    collaborator OTHER

  • University of Kansas

    lead OTHER

Principal Investigators

  • Janelle Ruisinger, Pharm.D. · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00603876 on ClinicalTrials.gov